Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 23: KABUKI: DOAC in Pts with CTEPH
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 1 year ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more

Prevention & Chronic Conditions
Recent Advances in Pulmonary Hypertension
Author(s): Akshyaya Pradhan , Richa Tyagi , Prachi Sharma , et al Added: 6 months ago

Heart Failure

Prevention & Chronic Conditions
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 8 months ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 7 months ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Gaps in Modern Heart Failure and Chronic Kidney Disease Research
Author(s): Simran Singh Parmar , Vasantha Muthuppalaniappan , Debasish Banerjee Added: 1 year ago

Heart Failure

Cardiovascular Renal Metabolic
2023 ESC Guidelines Update: Acute & Chronic Heart Failure
Author(s): Giuseppe Rosano , Harriette Van Spall Added: 1 year ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Prof Rosano summarises the retained ejection fraction… View more

Guidelines & Statements

Heart Failure
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 3 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Job title: Associate Professor of Cardiovascular Surgery
Dr Mert Dumantepe is an Associate Professor of Cardiovascular Surgery at Acibadem University School of Medicine, Turkey. He completed his graduation from Istanbul University School of Medicine, Turkey in 2001. He did a fellowship in chronic thromboembolic pulmonary hypertension and pulmonary endarterectomy and the heart transplantation and mechanical asist device programme at the University of… View more
ACC 25 Late-Breaking Discussion: The FRESH-UP Trial
Author(s): Harriette Van Spall , Roland RJ van Kimmenade Added: 3 months ago
ACC 25 - FRESH-UP shows liberal fluid intake did not result in a significant difference in health status compared to fluid restriction of 1500ml per day, but did result in a lower perceived thirst distress.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Roland Van Kimmenade (Radboud University Medical Center, Nijmegen, NL) to discuss the findings from the multi-center,… View more

Heart Failure
Research Area(s) / Expertise: Job title: Clinical Cardiologist and Professor of Vascular Biology